TY  - JOUR
AU  - Nadal, Ernest
AU  - Bautista, Dolores
AU  - Cabezón-Gutiérrez, Luis
AU  - Ortega, Ana Laura
AU  - Torres, Héctor
AU  - Carcedo, David
AU  - Ruiz de Alda, Lucía
AU  - Garcia, J Francisco
AU  - Vieitez, Paula
AU  - Rojo, Federico
PY  - 2021
DO  - 10.1186/s12885-021-08407-1
UR  - http://hdl.handle.net/10668/17984
T2  - BMC cancer
AB  - Currently biomarkers play an essential role in diagnosis, treatment, and management of cancer. In non-small cell lung cancer (NSCLC) determination of biomarkers such as ALK, EGFR, ROS1 or PD-L1 is mandatory for an adequate treatment decision. The aim...
LA  - en
KW  - Anaplastic Lymphoma Kinase
KW  - Biomarkers, Tumor
KW  - Carcinoma, Non-Small-Cell Lung
KW  - Clinical Decision-Making
KW  - Computer Simulation
KW  - Cost-Benefit Analysis
KW  - Decision Trees
KW  - Genetic Testing
KW  - Health Care Costs
KW  - Humans
KW  - Lung Neoplasms
KW  - Markov Chains
KW  - Models, Economic
KW  - Oncogene Proteins, Fusion
KW  - Precision Medicine
KW  - Progression-Free Survival
KW  - Quality-Adjusted Life Years
KW  - Spain
TI  - Clinical and economic impact of current ALK rearrangement testing in Spain compared with a hypothetical no-testing scenario.
TY  - research article
VL  - 21
ER  -